Faculty

Jane C. Shivnan, MScN, RN, AOCN (Chairperson)
Executive Director
The Institute for Johns Hopkins Nursing
Baltimore, MD

Randy Jones, PhD, RN
Assistant Professor
University of Virginia School of Nursing
Charlottesville, VA

Kristen Kreamer, MSN, CRNP, AOCN, APRN-BC
Nurse Practitioner
Thoracic Medical Oncology
Fox Chase Cancer Center
Philadelphia, PA

Sandra E. Kurtin, RN, MS, AOCN, ANP-C
Hematology/Oncology Nurse Practitioner
Arizona Cancer Center
Clinical Assistant Professor of Nursing
Clinical Assistant Professor of Medicine
University of Arizona
Tucson, AZ

Frances M. Palmieri, RN, MSN, OCN
Manager, Breast Clinic
and Breast Cancer Program
Mayo Clinic
Jacksonville, FL

Brenda Shelton, MS, RN, CCRN, AOCN
Clinical Nurse Specialist
The Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins
Baltimore, MD

Rita Wickham, PhD, RN, AOCN, CHPN
Associate Professor
College of Nursing
Rush University Medical Center
Chicago, IL

Conflict of Interest:

The following members of the planning committee and program faculty report financial relationships with companies providing program funding and/or manufacturers of commercial products they discuss in the program:

Jane C. Shivnan, MScN, RN, AOCN, reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Randy A. Jones, PhD, APRN, reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Kristen Kreamer, MSN, CRNP, AOCN, APRN-BC, reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Sandra E. Kurtin, RN, MS, AOCN, ANP-C, reports serving on the speakers¹ bureau for sanofi-aventis.

Frances M. Palmieri, RN, MSN, OCN, reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Brenda K. Shelton, MS, RN, CRN, AOCN, reports serving on the speakers¹ bureau for Amgen Inc.

Rita Wickham, PhD, RN, AOCN, CHPN, reports having no significant financial or advisory relationships with corporate organizations related to this activity.


OFF-LABEL USE:

The following members of the program faculty have indicated that they intend to discuss off-label or investigational use of products in their presentations:

Dr Jones and Ms Kreamer - gabapentin.